Multicystic peritoneal mesothelioma: a systematic review of the literature

Noiret, Barbara; Renaud, Florence; Piessen, Guillaume; Eveno, Clarisse

Document type :

Article dans une revue scientifique: Article original

DOI :

10.1515/pp-2019-0024

Title :

Multicystic peritoneal mesothelioma: a systematic review of the literature

Author(s) :

Noiret, Barbara [Auteur]
Hôpital Claude Huriez [Lille]
Renaud, Florence [Auteur]

Pôle de Biologie Pathologie Génétique [CHU Lille]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Piessen, Guillaume [Auteur]

Hôpital Claude Huriez [Lille]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Eveno, Clarisse [Auteur]

Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]

Journal title :

Pleura and peritoneum

Publisher :

Walter de Gruyter GmbH

Publication date :

2019-09-25

ISSN :

2364-7671

HAL domain(s) :

Sciences du Vivant [q-bio]/Cancer

English abstract : [en]

Abstract Multicystic peritoneal mesothelioma (MCPM) is a particularly rare and benign neoplasm that arises from the peritoneum in reproductive aged females. Its etiopathogenesis is still unclear. The current prevailing ...
Show more >Abstract Multicystic peritoneal mesothelioma (MCPM) is a particularly rare and benign neoplasm that arises from the peritoneum in reproductive aged females. Its etiopathogenesis is still unclear. The current prevailing theory supports the idea that the tumor is the result of an excessive inflammatory process. Because of a lack of clinical and imaging presentation, the diagnosis is intricate, and heavily relies on case reports and short studies. A histological analysis with immunohistochemistry is required for a definitive diagnosis. To date, there is no standard treatment recommended for MCPM. However, some studies suggest proceeding with a cytoreductive surgery and a hyperthermic intraperitoneal chemotherapy combining CISPLATIN and DOXORUBICIN, due to a high incidence of recurrence rate after medical treatment or surgery alone and potential malignant transformation.Show less >

Language :

Anglais

Peer reviewed article :

Oui

Audience :

Internationale

Popular science :

Non

Collections :